Alias
科研级 Dusigitumab ( 度司妥单抗 ), Anti-IGF1 & IGF2 Recombinant Antibody, Research Grade Dusigitumab
Molecular Name
Dusigitumab
Applications
Neut, ELISA, IF, IP, FuncS, FC, IHC
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
IGF1/IGF2[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGLF2. It was developed by MedImmune, which was acquired by AstraZeneca, using Xenomouse technology licensed from Abgenix.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。